Assessment of neovascular permeability in a pancreatic tumor model using dynamic contrast-enhanced (DCE) MRI with contrast agents of different molecular weights
- 13 May 2011
- journal article
- research article
- Published by Springer Nature in Magnetic Resonance Materials in Physics, Biology and Medicine
- Vol. 24 (4) , 225-232
Abstract
We evaluated the relationship of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI)-derived pharmacokinetic parameters and contrast agents with different molecular weights (MW) in a pancreatic tumor mouse model. Panc02 tumors were induced in mice at the hind leg. DCE-MRI was performed using Gadolinium (Gd)-based contrast agents with different MW: Gd-DOTA (0.5 kDa), P846 (3.5 kDa), and P792 (6.47 kDa). Quantitative vascular parameters (AUC, K trans, V e, and V p) were calculated according to a modified Tofts two-compartment model. Values for all contrast groups were compared for tumor and control (muscle) tissues. Values for K trans and V e were significantly higher in tumor tissue than in muscle tissue. When comparing contrast agents, lowest absolute K trans values were observed using P792. The relative increase in K trans in tumor tissue compared with normal tissue was highest after the use of P792. In both tumor and normal tissues, K trans decreased with increasing molecular weight of the contrast agent used. It was demonstrated that values for the different DCE-MRI vascular (permeability) parameters are highly dependent on the contrast agent used. Due to their potential to better differentiate tumor from muscle tissue, higher molecular weight contrast agents show promise when evaluating tumors using DCE-MRI.Keywords
This publication has 33 references indexed in Scilit:
- Precision analysis of kinetic modelling estimates in dynamic contrast enhanced MRIMagnetic Resonance Materials in Physics, Biology and Medicine, 2011
- Noninvasive Evaluation of Antiangiogenic Effect in a Mouse Tumor Model by DCE-MRI with Gd-DTPA Cystamine CopolymersMolecular Pharmaceutics, 2009
- P846, a new gadolinium based low diffusion magnetic resonance contrast agent, in characterizing occlusive infarcts, reperfused ischemic myocardium and reperfused infarcts in ratsMagnetic Resonance Materials in Physics, Biology and Medicine, 2008
- Fluctuations in tumor blood perfusion assessed by dynamic contrast‐enhanced MRIMagnetic Resonance in Medicine, 2007
- Recombinant human erythropoietin α modulates the effects of radiotherapy on colorectal cancer microvesselsBritish Journal of Cancer, 2007
- Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial resultsMagnetic Resonance Imaging, 2007
- Multi-Slice DCE-MRI Data Using P760 Distinguishes Between Metastatic and Non-Metastatic Rodent Prostate TumorsMagnetic Resonance Materials in Physics, Biology and Medicine, 2006
- New model for analysis of dynamic contrast‐enhanced MRI data distinguishes metastatic from nonmetastatic transplanted rodent prostate tumorsMagnetic Resonance in Medicine, 2004
- Functional tumor imaging with dynamic contrast‐enhanced magnetic resonance imagingJournal of Magnetic Resonance Imaging, 2003
- Tumor Angiogenesis: A New Significant and Independent Prognostic Indicator in Early-Stage Breast CarcinomaJNCI: Journal of the National Cancer Institute, 1992